Olga Sánchez- Maroto Carrizo I'm a graduate in Biology at the Universitat Autònoma de Barcelona. Since 2001 I have been linked to the world of clinical research in different positions. I have worked both in the public and private sphere. I have participated in different types of clinical research in various indications. Institutions of which they are part Cap d'Unitat Clinical Research Development Directorate Vall Hebron Institut de Recerca LinkedIn Twitter Olga Sánchez- Maroto Carrizo LinkedIn Twitter Institutions of which they are part Cap d'Unitat Clinical Research Development Directorate Vall Hebron Institut de Recerca I'm a graduate in Biology at the Universitat Autònoma de Barcelona. Since 2001 I have been linked to the world of clinical research in different positions. I have worked both in the public and private sphere. I have participated in different types of clinical research in various indications.
EDUCATION • Universitat de Barcelona, Master in Experimental Bioscience, 2001 • Universitat Autònoma de Barcelona, Bachelor in Biology. Microbiology specialist, 2000 ADDITIONAL RELEVANT TRAININGS • Programa de Alta Dirección en Instituciones Sanitarias. IESE. 2021. • Course on Human Rights and Bioethics in Clínics and Investigation. Universidad Nacional de Educación a Distancia. 2020 • Course on Biomedicine and Law Universidad Nacional de Educación a Distancia. 2019 • Project Management in Clinical Research. CESIF. 2018 • Basic Statisctics for Clinical Research. VHIR. March 2017 • Health and Law. Universidad Nacional de Educación a Distancia. 2008 PROFESSIONAL EXPERIENCE Period: April 2014 – Present Position: Unit Head Academic Research Organization Organization: VHIR – Institut de Recerca Vall d’Hebron Period: March 2013 – April 2014 Position: Sr. Associate Clinical Operations Manager Organization: Amgen Period: December 2012 – February 2013 Position: Sr. Associate Clinical Operations Manager Organization: Pharmanet i3 (in exclusive for Amgen) Period: January 2009 - July 2012 Position: Clinical Research Manager Organization: RPS Research Iberica, S.L.U, Period: September 2005 – January 2009 Position: Clinical Research Manager Organization: Infociencia Clinical Research, Period: November 2001 – September 2005 Position: Clinical Research Associated Organization: Infociencia Clinical Research
Projects EU Patient- cEntric clinicAl tRial pLatform - EU PEARL. IP: Joan Genescà Ferrer Collaborators: Santiago Pérez Hoyos, Anna Sanjuan Viaplana, EU Patient- cEntric clinicAl tRial pLatform - EU PEARL., EU Patient- cEntric clinicAl tRial pLatform - EU PEARL., Juan Espinosa Pereiro, Juan Manuel Pericàs Pulido, José Antonio Ramos Quiroga, Israel Molina Romero, Alex Sánchez Pla, Inmaculada Fuentes Camps, Adrián Sánchez Montalvá, Pol Ibañez Jimenez, Olga Sánchez- Maroto Carrizo, Gara Arteaga Henriquez, Alba Maria Jiménez Masip, EU Patient- cEntric clinicAl tRial pLatform - EU PEARL. Funding agency: The Innovative Medicines Initiative Funding: 1987375 Reference: EU-PEARL_H2020_IMI2-2018 Duration: 01/11/2019 - 30/04/2023 SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.. IP: - Collaborators: SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Olga Sánchez- Maroto Carrizo, Sandra Mancilla Zamora, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Belen Garcia Prats, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Maria Fidel Lledò, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Diana Fernandes de Rafael, Simon Schwartz Navarro Funding agency: EUROPEAN COMMISSION Funding: 649580 Reference: SAFE-N-MEDTECHEC_H2020-NMBP2018 Duration: 01/04/2019 - 30/09/2023 Spanish Clinical Research Network (SCReN) IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Spanish Clinical Research Network (SCReN), Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Joan Genescà Ferrer Funding agency: Instituto de Salud Carlos III Funding: 319550 Reference: PT17/0017/0030 Duration: 01/01/2018 - 31/12/2020 LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS IP: - Collaborators: Ester Palacio Gutierrez, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer Funding agency: EUROPEAN COMMISSION Funding: 409557 Reference: LIVERHOPE_H2020RTD2016 Duration: 01/01/2017 - 28/02/2023 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Next page › Last page »
